# Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms

> **NCT02569697** · PHASE1 · COMPLETED · sponsor: **CONRAD** · enrollment: 50 (actual)

## Conditions studied

- HIV

## Interventions

- **OTHER:** HEC Placebo gel
- **OTHER:** Placebo Intravaginal Ring
- **OTHER:** Placebo Vaginal Film
- **OTHER:** Placebo Vaginal Insert

## Key facts

- **NCT ID:** NCT02569697
- **Lead sponsor:** CONRAD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02569697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02569697, "Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02569697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*